DODGE & COXDODGE & COX

Institutional investor · Portfolio as of Q2 2026

Top Holdings222 positions

Checking export access…
Activity:

JOHNSON CONTROLS INTERNATION

55.8M$8.1B4.3%$36.44+318.35%
31 qtrssince 2018-Q4
Decreased
0

Charles Schwab Corp/The

77M$7.1B3.7%$44.43+117.85%
31 qtrssince 2018-Q4
Increased
60

RTX CORPORATION

35.1M$6.7B3.5%$62.48+198.44%
25 qtrssince 2020-Q2
Decreased
0

CVS Health Corp

50M$5.2B2.7%$57.68+56.72%
31 qtrssince 2018-Q4
Decreased
0

Microsoft Corp

12.8M$4.8B2.5%$227.75+134.33%
31 qtrssince 2018-Q4
Increased
59

Booking Holdings Inc

25.5M$4.6B2.4%$103.81+54.78%
31 qtrssince 2018-Q4
Increased
88

HUMANA INC

10.9M$4.3B2.3%$294.60+45.08%
9 qtrssince 2024-Q2
Decreased
0

Alphabet Inc

12M$4.2B2.2%$54.91+525.80%
31 qtrssince 2018-Q4
Decreased
0

METLIFE INC

48.4M$4.1B2.1%$32.94+202.73%
31 qtrssince 2018-Q4
Decreased
0

SUNBELT RENTALS HOLDINGS INC

54.8M$4.1B2.1%$64.45+17.32%
2 qtrssince 2026-Q1
Increased
56

Amazon.com Inc

16.7M$4B2.1%$115.65+119.70%
31 qtrssince 2018-Q4
Increased
61

Alphabet Inc

10.7M$3.8B2.0%$93.69+271.07%
31 qtrssince 2018-Q4
Increased
50

UnitedHealth Group Inc

9.1M$3.8B2.0%$288.70+37.04%
31 qtrssince 2018-Q4
Decreased
0

Meta Platforms Inc

6.5M$3.7B1.9%$431.48+70.93%
25 qtrssince 2020-Q2
Increased
63

OCCIDENTAL PETE CORP

72.8M$3.5B1.9%$37.00+65.98%
31 qtrssince 2018-Q4
Decreased
0

TE Connectivity PLC

17M$3.4B1.8%$155.15+35.52%
8 qtrssince 2024-Q3
Increased
58

Cigna Group/The

12.2M$3.4B1.8%$207.73+39.41%
31 qtrssince 2018-Q4
Increased
53

REGENERON PHARMACEUTICALS

4.9M$3B1.6%$616.43+26.27%
19 qtrssince 2021-Q4
Increased
55

Gilead Sciences Inc

23.7M$3B1.6%$52.66+191.59%
31 qtrssince 2018-Q4
Decreased
0

INTERNATIONAL FLAVORS&FRAGRA

37M$2.9B1.5%$77.72+15.28%
11 qtrssince 2023-Q4
Increased
51
$191B
AUM
222
Positions
Q2 2026
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+2%Q1'25$175.5B+1%Q2'25$178B+4%Q3'25$185.3B-0%Q4'25$185.3B-2%Q1'26$182B+5%Q2'26$191B
Activity profile
$ moved · Q2'26
New4%Increased45%Decreased47%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.2 years
<1Q3%1-4Q8%1-2Y10%2Y+80%

DODGE & COX manages $191B across 222 positions as of Q2 2026. Top holdings: JCI (4.3%), SCHW (3.7%), RTX (3.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.

Q2 2026 Summary

Active quarter - 9 new positions, 9 exits, 71 increased. Top move: BKNG (INCREASED, conviction 88). Portfolio: $191.0B across 222 positions.

Top holdings by portfolio weight

Total AUM$191B
JCI4.27%
SCHW3.72%
RTX3.49%
CVS2.71%
MSFT2.51%
BKNG2.38%
HUM2.28%
GOOG2.21%
MET2.15%
SUNB2.14%
Other2.08%

Portfolio allocation by GICS sector

Sectors11
Healthcare23.65%
Financial Services20.74%
Technology11.33%
Industrials10.97%
Communication Services10.88%
Consumer Cyclical6.57%
Energy4.47%
Basic Materials4.33%
Consumer Defensive2.32%
Real Estate2.11%
Other2.64%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Financial Services, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L76
Conviction37
Concentration42
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
CMCSACMCSACOMCAST CORP NEW
Q4 2024 → Q2 2026+41.8M shares-$248.2M
7Q
CPNGCPNGCOUPANG INC
Q4 2024 → Q2 2026+52.1M shares+$760.4M
7Q
LPLALPLALPL FINL HLDGS INC
Q4 2024 → Q2 2026+4.6M shares+$1.3B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used